{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:09:26Z","timestamp":1765483766532,"version":"3.37.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.encep.2009.06.005","type":"journal-article","created":{"date-parts":[[2009,9,20]],"date-time":"2009-09-20T08:10:55Z","timestamp":1253434255000},"page":"D133-D138","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S2","title":["Traitement par inhibiteurs s\u00e9lectifs de la recapture de la s\u00e9rotonine de la d\u00e9pression chez la femme enceinte\u00a0: risques pour le f\u0153tus et le nouveau-n\u00e9"],"prefix":"10.1016","volume":"36","author":[{"given":"S.","family":"Favreli\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nourrisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"P\u00e9rault Pochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2009.06.005_bib1","doi-asserted-by":"crossref","unstructured":"ACOG Committee on Obstetric Practice. ACOG Committee opinion No\u00a0354: Treatment with selective serotonin reuptake inhibitors during pregnancy. Obstet Gynecol 2006;108(6):1601\u20133.","DOI":"10.1097\/00006250-200612000-00058"},{"issue":"12","key":"10.1016\/j.encep.2009.06.005_bib2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1017\/S003329170600835X","article-title":"To treat or not treat depression. SSRI use in pregnancy and adverse neonatal effects","volume":"36","author":"Austin","year":"2006","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.encep.2009.06.005_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","article-title":"Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors","volume":"29","author":"Bar-Oz","year":"2007","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.encep.2009.06.005_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0028-2243(79)90003-0","article-title":"5-Hydroxytryptamine, cooper and ceruloplasmin plasma concentrations in spontaneous abortion","volume":"9","author":"Bassiouni","year":"1979","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.encep.2009.06.005_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00044011-200424030-00004","article-title":"Depression during pregnancy","volume":"24","author":"Bennett","year":"2004","journal-title":"Clin Drug Investig"},{"issue":"11","key":"10.1016\/j.encep.2009.06.005_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/070674370404901103","article-title":"Perinatal risks of untreated depression during pregnancy","volume":"49","author":"Bonari","year":"2004","journal-title":"Can J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2009.06.005_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":"Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy","volume":"142","author":"Casper","year":"2003","journal-title":"J Pediatr"},{"issue":"14","key":"10.1016\/j.encep.2009.06.005_bib8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"New Eng J Med"},{"issue":"6","key":"10.1016\/j.encep.2009.06.005_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Eng J Med"},{"issue":"5","key":"10.1016\/j.encep.2009.06.005_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.295.5.499","article-title":"Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment","volume":"295","author":"Cohen","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.encep.2009.06.005_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.encep.2009.06.005_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1073\/pnas.0606722104","article-title":"Maternal serotonin is crucial for murine embryonic development","volume":"104","author":"Cote","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.encep.2009.06.005_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2125.2003.01906.x","article-title":"Neonatal intraventricular haemorrhage associated with maternal use of paroxetine","volume":"56","author":"Duijvestijn","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.encep.2009.06.005_bib14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1701-2163(16)30500-X","article-title":"Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice","volume":"27","author":"Einarson","year":"2005","journal-title":"J Obstet Gynecol Can"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2009.06.005_bib15","first-page":"43","article-title":"Psychotrope and pregnancy","volume":"29","author":"Elefant","year":"2000","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"1","key":"10.1016\/j.encep.2009.06.005_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.2006-2133","article-title":"Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates","volume":"119","author":"Ferreira","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.encep.2009.06.005_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.infbeh.2006.03.003","article-title":"Prenanal depression effects on the fetus and the newborn: a review","volume":"29","author":"Field","year":"2006","journal-title":"Infant Behav Dev"},{"issue":"7","key":"10.1016\/j.encep.2009.06.005_bib18","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1096\/fj.07-100743","article-title":"Maternal serotonin influences cardiac function in adult offspring","volume":"22","author":"Fligny","year":"2008","journal-title":"FASEB"},{"issue":"10","key":"10.1016\/j.encep.2009.06.005_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.200701-163OC","article-title":"Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat","volume":"176","author":"Fornaro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.encep.2009.06.005_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1345\/aph.1E547","article-title":"Antidepressant use during pregnancy and the rates of spontaneous abortions; a meta-analysis","volume":"39","author":"Hemels","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.encep.2009.06.005_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2009.06.005_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.grf.0000135341.48747.f9","article-title":"The fetus and maternal depression: implications for antenatal treatment guidelines","volume":"47","author":"Henry","year":"2004","journal-title":"Clin Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.encep.2009.06.005_bib23","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1503\/cmaj.1041100","article-title":"Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?","volume":"172","author":"Koren","year":"2005","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.encep.2009.06.005_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","article-title":"Delivery outcome in relation to maternal use of some recently introduced antidepressants","volume":"27","author":"Lennestal","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"26","key":"10.1016\/j.encep.2009.06.005_bib25","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.encep.2009.06.005_bib26","first-page":"28A","article-title":"Infant social behavior and development in the first year of life following prolonged prenatal psychotropic medication exposure","volume":"49","author":"Morrison","year":"2001","journal-title":"Pediatr Res"},{"issue":"19","key":"10.1016\/j.encep.2009.06.005_bib27","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.encep.2009.06.005_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of children exposed in utero to antidepressant drugs","volume":"336","author":"Nulman","year":"1997","journal-title":"New Eng J Med"},{"issue":"11","key":"10.1016\/j.encep.2009.06.005_bib29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2009.06.005_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1203\/00006450-200204000-00008","article-title":"Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response","volume":"51","author":"Oberlander","year":"2002","journal-title":"Pediatric Res"},{"issue":"4","key":"10.1016\/j.encep.2009.06.005_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.reprotox.2006.03.019","article-title":"Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials","volume":"22","author":"Rahimi","year":"2006","journal-title":"Reprod Toxicol"},{"issue":"8","key":"10.1016\/j.encep.2009.06.005_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.33588\/rn.3608.2002521","article-title":"Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine","volume":"36","author":"Salvia-Roiges","year":"2003","journal-title":"Rev Neurol"},{"issue":"9458","key":"10.1016\/j.encep.2009.06.005_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.encep.2009.06.005_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-3057(93)90147-L","article-title":"In utero exposure to fluoxetine HCL increases hematoma frequency at birth","volume":"45","author":"Stanford","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.encep.2009.06.005_bib35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.2007.06071172","article-title":"Effects of antenatal depression and antidepressant treatment on gestational age of birth and risk of preterm birth","volume":"164","author":"Suri","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2009.06.005_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ar.10089","article-title":"Changing distribution of monoaminergic markers in the developing cerebral cortex with special emphasis on the serotonin transporter","volume":"267","author":"Verney","year":"2002","journal-title":"Anat Rec"},{"key":"10.1016\/j.encep.2009.06.005_bib37","first-page":"182","article-title":"Paroxetine and congenital malformations: a prospective comparative study","volume":"20","author":"Vial","year":"2006","journal-title":"Fund Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.encep.2009.06.005_bib38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","article-title":"Selective serotonin reuptake inhibitors and adverse pregnancy outcome","volume":"194","author":"Wen","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.encep.2009.06.005_bib39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1503\/cmaj.051421","article-title":"Paroxetine and congenital malformations","volume":"173","author":"Williams","year":"2005","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.encep.2009.06.005_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations","volume":"17","author":"Wogelius","year":"2006","journal-title":"Epidemiology"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700609001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700609001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T08:00:28Z","timestamp":1739347228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700609001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":40,"alternative-id":["S0013700609001456"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2009.06.005","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}